101 related articles for article (PubMed ID: 25935857)
21. Radiotherapy in the Management of Orbital Lymphoma: A Single Institution's Experience Over 4 Decades.
Kharod SM; Herman MP; Morris CG; Lightsey J; Mendenhall WM; Mendenhall NP
Am J Clin Oncol; 2018 Jan; 41(1):100-106. PubMed ID: 26398063
[TBL] [Abstract][Full Text] [Related]
22. A prospective phase II trial of response adapted whole brain radiotherapy after high dose methotrexate based chemotherapy in patients with newly diagnosed primary central nervous system lymphoma-analysis of acute toxicity profile and early clinical outcome.
Adhikari N; Biswas A; Gogia A; Sahoo RK; Garg A; Nehra A; Sharma MC; Bhasker S; Singh M; Sreenivas V; Chawla R; Joshi G; Kumar L; Chander S
J Neurooncol; 2018 Aug; 139(1):153-166. PubMed ID: 29633112
[TBL] [Abstract][Full Text] [Related]
23. Clinical stage IEA-IIEA orbital lymphomas: outcomes in the era of modern staging and treatment.
Pelloski CE; Wilder RB; Ha CS; Hess MA; Cabanillas FF; Cox JD
Radiother Oncol; 2001 May; 59(2):145-51. PubMed ID: 11325442
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis and treatment of orbital malignant lymphoma: a 14-year review at Yamagata University.
Takamura H; Terashima K; Yamashita H
Jpn J Ophthalmol; 2001; 45(3):305-12. PubMed ID: 11369383
[TBL] [Abstract][Full Text] [Related]
25. Induction chemotherapy plus three-dimensional conformal radiation therapy in the definitive treatment of locally advanced non-small-cell lung cancer.
Sim S; Rosenzweig KE; Schindelheim R; Ng KK; Leibel SA
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):660-5. PubMed ID: 11597806
[TBL] [Abstract][Full Text] [Related]
26. Therapy and outcome of orbital primitive neuroectodermal tumor.
Bakhshi S; Meel R; Naqvi SG; Mohanti BK; Kashyap S; Pushker N; Sen S
Pediatr Blood Cancer; 2009 Apr; 52(4):544-7. PubMed ID: 19090547
[TBL] [Abstract][Full Text] [Related]
27. [Role of modified radiotherapy in the combined treatment of orbital non-Hodgkin lymphoma].
Vinogradova IuN; Il'in NV; Bochkareva TN; Cherviakov AM; Leenman EE
Vopr Onkol; 2009; 55(1):93-8. PubMed ID: 19435208
[TBL] [Abstract][Full Text] [Related]
28. Stage I and II MALT lymphoma: results of treatment with radiotherapy.
Tsang RW; Gospodarowicz MK; Pintilie M; Bezjak A; Wells W; Hodgson DC; Crump M
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1258-64. PubMed ID: 11483337
[TBL] [Abstract][Full Text] [Related]
29. [Results of therapy for orbital malignant lymphoma].
Takamura H; Terashima K; Yamashita H
Nippon Ganka Gakkai Zasshi; 2000 Nov; 104(11):813-8. PubMed ID: 11530372
[TBL] [Abstract][Full Text] [Related]
30. Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET.
Halasz LM; Jacene HA; Catalano PJ; Van den Abbeele AD; Lacasce A; Mauch PM; Ng AK
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e647-54. PubMed ID: 22607911
[TBL] [Abstract][Full Text] [Related]
31. Treatment results of tonsillar lymphoma: a 10-year experience.
Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
[TBL] [Abstract][Full Text] [Related]
32. A retrospective analysis of different modalities for treatment of primary orbital non-Hodgkin's lymphomas.
Esik O; Ikeda H; Mukai K; Kaneko A
Radiother Oncol; 1996 Jan; 38(1):13-8. PubMed ID: 8850421
[TBL] [Abstract][Full Text] [Related]
33. Carboplatin/paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy: report of a prospective phase I dose escalation trial from the Carolina Conformal Therapy Consortium.
Marks LB; Garst J; Socinski MA; Sibley G; Blackstock AW; Herndon JE; Zhou S; Shafman T; Tisch A; Clough R; Yu X; Turrisi A; Anscher M; Crawford J; Rosenman J;
J Clin Oncol; 2004 Nov; 22(21):4329-40. PubMed ID: 15514374
[TBL] [Abstract][Full Text] [Related]
34. [Initial outcome of induction chemotherapy with weekly paclitaxel followed by three-dimensional conformal radiotherapy and concurrent weekly paclitaxel for stage III non-small cell lung cancer].
Wang WH; Bao Y; Chen M; Zhang L; Li KX; Xu GC; Deng XW; Lu TX; Cui NJ
Ai Zheng; 2006 Oct; 25(10):1279-83. PubMed ID: 17059776
[TBL] [Abstract][Full Text] [Related]
35. Chemotherapy and late course three dimensional conformal radiotherapy for treatment of patients with stage III non- small cell lung cancer.
Liu YC; Zhou SB; Gao F; Ye HX; Zhao Y; Yi XX; Huang XE; Xiang J
Asian Pac J Cancer Prev; 2013; 14(4):2663-5. PubMed ID: 23725192
[TBL] [Abstract][Full Text] [Related]
36. Nasopharyngeal carcinoma: Experience and treatment outcome with radical conformal radiotherapy from a tertiary care center in India.
Kunheri B; Agarwal G; Sunil PS; Nair AR; Pushpaja KU
Indian J Cancer; 2017; 54(3):502-507. PubMed ID: 29798947
[TBL] [Abstract][Full Text] [Related]
37. Localized ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiation therapy: a long-term outcome in 86 patients with 104 treated eyes.
Harada K; Murakami N; Kitaguchi M; Sekii S; Takahashi K; Yoshio K; Inaba K; Morota M; Ito Y; Sumi M; Suzuki S; Tobinai K; Uno T; Itami J
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):650-4. PubMed ID: 24521680
[TBL] [Abstract][Full Text] [Related]
38. [Results of definitive radiotherapy for squamous cell carcinomas of the larynx patients with subglottic extension].
Lévy A; Blanchard P; Janot F; Temam S; Bourhis J; Daly-Schveitzer N; Tao Y
Cancer Radiother; 2014 Jan; 18(1):1-6. PubMed ID: 24309002
[TBL] [Abstract][Full Text] [Related]
39. [Preliminary results of three-dimensional conformal radiotherapy for small-cell lung cancer].
Wang YJ; Wang LH; Chen DF; Zhou ZM; Ou GF; Liang J; Zhang K; Yin WB
Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):570-2. PubMed ID: 16438861
[TBL] [Abstract][Full Text] [Related]
40. Induction chemotherapy with carboplatin, irinotecan, and paclitaxel followed by high dose three-dimension conformal thoracic radiotherapy (74 Gy) with concurrent carboplatin, paclitaxel, and gefitinib in unresectable stage IIIA and stage IIIB non-small cell lung cancer.
Stinchcombe TE; Morris DE; Lee CB; Moore DT; Hayes DN; Halle JS; Rivera MP; Rosenman JG; Socinski MA
J Thorac Oncol; 2008 Mar; 3(3):250-7. PubMed ID: 18317067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
